ZCZC
BFF-04
VACCINE-JOHNSON-TRIAL-PAUSE
Johnson & Johnson pauses Covid vaccine trial as participant becomes ill
WASHINGTON, Oct 13, 2020 (BSS/AFP) – Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.
“We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant,” the company said in a statement.
The pause means the online enrollment system has been closed for the 60,000-patient clinical trial while the independent patient safety committee is convened.
BSS/AFP/MMA/0815HRS